(Q34002800)

English

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2. (English)

1 reference

Europe PubMed Central

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

A Hamilton

1

1 reference

Europe PubMed Central

30 July 2017

M Piccart

2

1 reference

Europe PubMed Central

30 July 2017

publication date

1 June 2000

1 reference

Europe PubMed Central

30 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

Europe PubMed Central

30 July 2017

6

1 reference

Europe PubMed Central

30 July 2017

647-663

1 reference

Europe PubMed Central

30 July 2017

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

The hunt for Ras targets

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis meets signal transduction: elimination of a BAD influence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlling cell death

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible mechanisms in the emergence of tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

The regulation of p53 function: Steiner Award Lecture.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Double identity for proteins of the Bcl-2 family

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Injected cytochrome c induces apoptosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

P53 Expression and the Result of Adjuvant Therapy of Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of drug resistance proteins in breast cancer, in relation to chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

bcl-2 protein in invasive ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390429428

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008390429428

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34002800&oldid=1521532747"